Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, +61

Nature

VaccinationNeuro-oncologyVaccination TrialVaccine TrialTherapeutic Vaccine +4

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

Line Pedersen, Manja Idorn, Gitte Holmen Olofsson, +12

Cell Metabolism

Cancer ImmunosurveillanceTumor MicroenvironmentImmunologyImmune Checkpoint InhibitorCell Proliferation +6

SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

David Olagnier, Ensieh Farahani, Jacob Thyrsted, +35

Nature Communications

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer

Manja Idorn, Tania Køllgaard, Per Kongsted, +2

Cancer Immunology Immunotherapy

UrologyGenitourinary CancerMedicineNegative Prognostic MarkersMalignant Blood Disorder +5

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, +44

Nature Communications

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry

Julián Valero, Laia Civit, Daniel M. Dupont, +13

Proceedings of the National Academy of Sciences

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection

Renée M. van der Sluis, Lamin B. Cham, Albert Gris‐Oliver, +22

The EMBO Journal

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1

Ruoshi Peng, Chris Kedong Wang, Xuan Wang‐Kan, +15

EMBO Reports

ApoptosisImmunologyImmune RegulationCell DeathImmunologic Mechanism +15

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

Manja Idorn, Signe K. Skadborg, Lauge Kellermann, +4

OncoImmunology

ImmunologyImmunoeditingImmunotherapeuticsMalignant MelanomaImmune Cell Therapy +21

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Marco Donia, Katja Harbst, Marit van Buuren, +20

Cancer Research